LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.36 | 84.90 | 2279 | 5651 | 0.4033 | 0.7215 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.06 | 84.90 | 2444 | 5990 | 0.4080 | 0.7283 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.06 | 84.90 | 2506 | 5990 | 0.4183 | 0.7354 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.06 | 84.90 | 2326 | 5990 | 0.3883 | 0.7144 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.06 | 84.90 | 2384 | 5990 | 0.3979 | 0.7213 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.77 | 84.90 | 2561 | 6252 | 0.4096 | 0.7319 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.77 | 84.90 | 2625 | 6252 | 0.4198 | 0.7388 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.77 | 84.90 | 2436 | 6252 | 0.3896 | 0.7180 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.77 | 84.90 | 2490 | 6252 | 0.3982 | 0.7241 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 84.90 | 2688 | 6567 | 0.4093 | 0.7345 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 84.90 | 2752 | 6567 | 0.4190 | 0.7411 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 84.90 | 2534 | 6567 | 0.3858 | 0.7183 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 84.90 | 2604 | 6567 | 0.3965 | 0.7258 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.18 | 84.90 | 2790 | 6963 | 0.4007 | 0.7320 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.18 | 84.90 | 2850 | 6963 | 0.4093 | 0.7378 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.18 | 84.90 | 2632 | 6963 | 0.3780 | 0.7162 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.18 | 84.90 | 2703 | 6963 | 0.3882 | 0.7234 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.88 | 84.90 | 2915 | 7291 | 0.3998 | 0.7340 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.88 | 84.90 | 2979 | 7291 | 0.4085 | 0.7399 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.88 | 84.90 | 2735 | 7291 | 0.3751 | 0.7169 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.88 | 84.90 | 2838 | 7291 | 0.3892 | 0.7268 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.59 | 84.90 | 2921 | 7641 | 0.3822 | 0.7246 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.59 | 84.90 | 3082 | 7641 | 0.4033 | 0.7389 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.59 | 84.90 | 2825 | 7641 | 0.3697 | 0.7158 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 60.59 | 84.90 | 2967 | 7641 | 0.3883 | 0.7288 | MN20160318_Q02 | L09 |